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ABSTRACT

Bacteria developed resistance to penicillin a mere four years after the groundbreaking antibiotic was first mass produced (Casadevall, 2010). Since then, the
development of antibiotic-resistant bacteria has steadily risen, causing millions of
difficult to treat infections annually. The challenge is to identify ways to combat these
menacing microbes. Bacteriophages are viruses that infect bacteria and can potentially be
used to eliminate deadly antibiotic-resistant bacteria. The number of sequenced
bacteriophage genomes has increased tremendously over the past 10 years, but little is
known about the function of most bacteriophage genes. The purpose of this study was to
expand our understanding of bacteriophage gene function by identifying genes that are
essential for lytic growth of bacteriophage HK639. Using recombineering, a genome
engineering technique, five HK639 genes and one regulatory sequence were individually
replaced with a kanamycin gene. The recombinants were selected on kanamycin plates,
and the gene replacements were confirmed by Polymerase Chain Reaction (PCR). To
determine if the replaced genes and regulatory sequence were essential for lytic growth,
the recombinants were tested for the release of viable phage. Phage production was
unaffected by four of the gene replacements, which indicates the replaced genes are not
essential for lytic growth. However, replacement of ORF 40 prevented phage growth.
These results indicate that ORF 40 performs an essential function. Biochemical analysis
of these proteins will be necessary since sequence analysis did not reveal any clues about
the potential function of ORF 40.
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INTRODUCTION

Antibiotic-resistant bacteria are an increasing threat to public health. Escherichia
coli, Mycobacterium tuberculosis, and Neisseria gonorrhoeae are among several
pathogenic bacteria that frequently do not respond to previously effective antibiotics. It is
estimated that antibiotic-resistant bacteria infect two million Americans every year
(CDC, 2020). By 2050, nearly ten million deaths will occur globally every year due to
antibiotic-resistant bacterial infections (O’Neill, 2014). A solution to this impending
disaster must be identified.
Bacteriophages, or viruses that infect bacteria, are natural bactericidal agents that
could be used to destroy antibiotic-resistant bacteria. Bacteriophages exterminate their
hosts by producing enzymes that attack the cell wall. In some cases, these enzymes have
been purified and shown to eliminate targeted bacteria (Roach et al., 2013, Fischetti,
2008). In order to be effectively used to fight human bacterial infections, it is crucial to
understand the life cycle of bacteriophages. In this study, genes required for the growth of
a unique E. coli bacteriophage, phage HK639, were identified. Knowing which genes are
essential for bacteriophage growth will offer important insight into phage biology and
increase their usefulness as therapeutic agents.
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Bacteriophages infect their host by attaching to a receptor located on the bacterial
cell’s surface. Once attached, the phage injects its genetic material into the host cell.
Temperate phage can adopt one of two life cycles: lytic or lysogenic (Figure 1). In the
lytic life cycle, the phage hijacks
the host’s macromolecular
synthesis machinery to create
new viral particles, which
ultimately escape by lysing the
host cell. In the lysogenic life
Figure 1: Lytic and lysogenic life cycles (Doss et al., cycle, the bacteriophage
2017). The phage genomic DNA is colored black.
The bacterial (host) chromosome is colored light
integrates its DNA into the host
gray.
cell’s chromosome, becoming a
prophage (a dormant bacteriophage). When the bacterial host replicates, the integrated
phage genome is also replicated as part of the host genome. Therefore, each cell division
creates an expanding population of infected bacterial cells. The bacteriophage remains
quiescent within the host bacterium until an appropriate signal reactivates the virus. DNA
damage is an event that often leads to the reactivation of prophages, causing the phage to
enter the lytic cycle and exit the bacterial host (Little, 2005).
Phage λ is the best-characterized temperate phage. Since its discovery in 1951,
phage λ has been studied extensively and has provided important insight into our
understanding of how bacteriophage genes are regulated. For example, a unique
mechanism of gene regulation, called transcription antitermination, was first discovered
in this phage. During this process, the host RNA polymerase (RNAP) is modified to read
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through transcription terminators or “stop” sequences. Most lambdoid phages utilize
protein-mediated antitermination. This occurs when proteins produced by both the phage
and the host cell modify the host RNA polymerase and convert it into a termination
resistant form. However, a rarer method of antitermination, called RNA-mediated
antitermination, was discovered in the lambdoid phage HK022. In this case, there is not a
protein that interacts with RNAP. Instead, the RNA transcript of the put (polymerization
utilization) sites folds into a highly organized, two stem-loop structure that directly
converts RNAP into a terminator-resistant form (King et al., 1996). E. coli bacteriophage
HK639 was chosen for this study because it also uses this poorly understood mechanism
of gene regulation and because the genes essential for phage growth are unknown.
Only a small portion of viral genes have known functions. In fact, it is unknown
whether a large portion of genes in most E. coli bacteriophages are even necessary for
lytic growth. The early genes of lambdoid phages are characteristically organized into
two divergently transcribed operons; named “left” and “right” to signify the direction of
transcription. Bacteriophage HK022 has no genes in the left operon that are essential for
lytic growth (Cam et al., 1990). This was shown by deleting the left operon promoter and
demonstrating that this did not prevent phage production. In contrast, a similar mutation
in phage HK639 prevented phage release from an HK639 lysogen (Seaton, 2013). To
determine which HK639 left operon genes were essential for phage growth, large
sections were systematically replaced (Seaton, 2013). The replacement of the first five
genes, after the terminator, of the HK639 left operon (Figure 2) prevented phage growth
and suggested that at least one of these five genes plays a vital role in lytic phage growth.
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In Figure 2, ORF 39, ORF 40, ORF 41, ORF 42, and ORF 43 were replaced by the
kanamycin gene, as defined in the previous study.

Figure 2: The top map shows the original HK639 genome and the bottom shows the
replacement of five early genes with the kanamycin gene (colored in pink). The combined
replacement of the first five genes of the HK639 left operon prevented phage growth.
Maps were generated using Geneious software.
Recombineering is a powerful chromosomal engineering technique. It involves
inserting or deleting DNA sequences in vivo using natural recombination functions within
cells (Marinelli et al., 2012). To successfully replace a genetic sequence in vivo, two
essential components must be prepared: a pure DNA fragment specifically designed to
recombine with the desired sequence and bacterial cells competent for completing the
recombination event. Electroporation, a brief electric shock, is used to introduce the
substrate DNA into host cells where the proteins responsible for mediating recombination
catalyze the reaction. The specifically designed DNA fragment recombines at identical
sequences flanking the replacement location in the genome, effectively replacing the
desired sequence (Figure 3).

Figure 3: In this example, recombineering is
used to replace genes and regulatory
sequences with the kanamycin gene. The
orange and purple regions flanking the
kanamycin gene are homologous to the
corresponding regions in the bacteriophage
HK639 genome. This homology allows the
kanamycin gene to recombine into the
chromosome and replace the targeted
sequences.
4

Our knowledge of how bacteriophage control their gene expression is very
limited. To serve as effective tools against antibiotic-resistant bacteria, it is vital to
understand how these viruses work. This study focuses on understanding gene expression
in bacteriophage HK639. HK639 is unusual in that it uses RNA-mediated antitermination
to promote the full expression of its early genes and it must express genes in the left
operon to successfully complete the lytic growth cycle. The purpose of this project was to
identify essential genes and regulatory sequences in the left operon of bacteriophage
HK639 using recombineering (Figure 4). After confirming the recombinants, the effect of
each substitution on phage growth was determined.

Figure 4: Maps showing the individual replacement of genes or regulatory sites in the
HK639 left operon. Maps were generated using Geneious software (Biomatters, Inc., San
Diego, CA).
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MATERIALS AND METHODS

Summary:
Several steps were required to locate essential genes in HK639 for lytic growth.
First, the DNA substrate for recombination was prepared; the kanamycin gene, flanked
by regions of homology to the desired chromosomal target, was amplified by Polymerase
Chain Reaction (PCR). Next, electrocompetent E. coli cells containing the HK639
prophage were prepared. These strains carried a plasmid, pRK1006, that allowed the
recombination proteins to be expressed after a heat induction event. After moving the
DNA substrate into the cells and allowing the recombination reaction to take place, the
recombinants were selected for by growing them in the presence of kanamycin. PCR was
performed to ensure the kanamycin gene had recombined in the correct location using the
oligonucleotide list in Table 2. These PCR products were visualized on an agarose gel
and sequenced to verify the recombination junctions. Lastly, the recombinant cells were
tested for phage release. If phage were released, PCR was performed to verify they were
indeed recombinant. A total of five genes and a regulatory sequence in the left operon
were individually replaced.

Bacterial Strains, Plasmids, and Bacteriophage:
The bacterial strains, plasmids, and bacteriophage used during this experiment are
shown in Table 1.
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Media for Plates:
The recipes for the bacteriological media used to make the plates are given: LB
plates (per liter): 10 g Tryptone, 5 g yeast extract, 5 g NaCl, and 15 g agar. TB top agar
(per liter): 10 g Tryptone, 5 g NaCl, and 7 g agar.

Table 1: Bacterial strains, plasmids, and bacteriophage used in this study.
Strains

Relevant Characteristics/Genotype

Reference

MC1000
RK1097

20
21

RK898

Δ(lac)X74
MG1655(HK022 @ tRNAgly at 10Kb)
rpoC+/pLUXam; SB1424/pSB1326; ampR,
camR, kanR
MC1000 (HK639) transformed with
pRK1006; ampR
RW4198 = MG1655; wild-type, rpoC+

RK899

RW4200 = MG1655; rpoCY75N

RK1372

RK1145 Δ33,095-33,200::kanR, kanamycin
replacing two terminators in left operon
RK1145 Δ32,178-32,383::kanR, kanamycin
replacing ORF 41
RK1145 Δ32,384-32,535::kanR, kanamycin
replacing ORF 42
RK1145 Δ31,811-32,096::kanR, kanamycin
replacing ORF 40
RK1145 Δ32,532-33,050::kanR, kanamycin
replacing ORF 43
RK1145 Δ30,886-32,906::kanR, kanamycin
replacing ORF 40 and ORF 39
RK1145 Δ30,866-31,808::kanR, kanamycin
replacing ORF 39

RK1145

RK1373
RK1374
RK1377
RK1379
RK1385
RK1386

King, R.
Weisburg, R.
unpublished
Weisburg, R.
unpublished
Carroll, A. and Urso, O.
This study
Urso, O.
This study
Urso, O.
This study
Carroll, A.
This study
Carroll, A.
This study
Urso, O. and Carroll, A.
This study
Carroll, A. and Urso, O.
This study

Plasmid
pRK1006 pSim6 [= ori-pSC101repA(ts) (cI857 PLexo-bet-gam;ampR)]
Phage
HK639
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4

Table 2: Oligonucleotide list in which the oligos were ordered from Integrated DNA
Technologies (IDT)
Oligo Sequence
Use
290
TTgCCATgTTTCAgAAACAACTC
Verification of
Terminators, ORF 39, 40,
41, and 43.
291
gATCTTgCCATCCTATggAAC
Verification of
Terminators, ORF 39, 40,
41, 42, and 43
568
CGGCAACATCGACAACTTTG
Verification of ORF 39
570
CGCGGCAAGCCAAAATATAG
Verification of Terminators
and ORF 43
729
GAATCAGTCAGCTTTGCGAAATCATTGG Recombineering for ORF
CGATCT
39
GGTAAAGAGCTGTCATgtggaccagttggtgatttt
g
748
TGGCCCCAAAACTGTATCTCCTCGAATA Recombineering for
CGCAGC
Terminators
CTCACTAATTAAGTAAtccgacaaccgatgaaagc
749
CGCTTAAGGCCGCGCCGCCGAACGTTAA Recombineering for
ACAAG
Terminators
ACTTCTGCGCTTGTGCGgtggaccagttggtgatttt
g
750
AAGCGCAGAAGTCTTGTTTAACGTTCGG Recombineering for ORF
CGGCG
43
CGGCCTTAAGCGCGGAGtccgacaaccgatgaaa
gc
751
TCGTTGAGCTTTTTGGCGGTGTACTGCTT Recombineering for ORF
GCCGT
43
TGTGGGTGACTGTCATgtggaccagttggtgattttg
752
ACATTGACGCCATCAATGCGGCAAATGC Recombineering for ORF
CAAAG
42
CCAGGGAGGCATCATGAtccgacaaccgatgaaa
gc
753
AAAACCTCGCTACGTGGCACTGATGCGG Recombineering for ORF
TGCCATAGTGCATTCCGATCATgtggaccagt 42
tggtgattttg
754
GGCAGATGCATATCGCTGGCCTCCTGAA Recombineering for ORF
ACAGG
41
TTGAGGTGAAGGTATGAtccgacaaccgatgaaa
gc
755
GATCCCGCCCGCAAAAAGCCAGGCCGA Recombineering for ORF
TCGGTT
41
GAATAGGGTGGTTAATAgtggaccagttggtgatt
ttg
8

756

758
760

CTGGCTTTTTGCGGGCGGGATCTGCACA
TCCAAA
TTTCAGGAGTTCAGCCtccgacaaccgatgaaagc
GGCTCCTGCTCCTTTACGAACTGAATCA
GATCGA
AGCTCATAATCACTCCgtggaccagttggtgattttg
CATGCTGGACCATCTCAACC
GTGGTGTTGCAGCATTGTGC

761

CTTAACTGGCACTGCACTTAAC

762
763

GTATGGGCTGGAGTCAATCG
CATCATCAAAAGTGATTCCGTCG

764
804

ACGTTGATAATCGCGTTCTGG
ACGCCCAGGCGGAATACGACTGGGAAC
ACCGTA
CCGGCTGCCCGTTTTAAtccgacaaccgatgaaag
c
GAAATCATTGGCGATCTGGTAAAGAGCT Recombineering for ORF
GTCAT
39
TGCGTAACCTCTTCGAATTTTGgtggaccagtt
ggtgattttg

757

805

Recombineering for ORF
39 and 40
Recombineering for ORF
40
Verification of Terminators
Verification of ORF 42 and
43
Verification of ORF 41 and
42
Verification of ORF 41
Verification of ORF 39 and
40
Verification of ORF 40
Recombineering for ORF
39

Generating the Recombination Substrate:
To generate the substrate for recombineering, the kanamycin gene was amplified
using PCR. The kanamycin gene was flanked by oligonucleotides (oligos) that were
designed to incorporate approximately 50 bp of sequence homology to the targeted region
on the phage genome (Table 2). The Phusion High Fidelity PCR Kit (NEB Cat. No.
E0553L) was used to amplify the kanamycin resistant gene since high-fidelity was
required for this reaction. The Phusion enzyme is a high-fidelity polymerase and creates
products with blunted ends. The error rate for this enzyme is nearly >50 fold lower than
that for Taq polymerase.
A typical 100 μL reaction contained the following components: 73 μL water, 20
μL HF buffer (1X final concentration), 100 pmol of each oligo primer from IDT (Table
9

2), 2 μL 10mM deoxynucleotide mix (dNTP), 2 μL of cell suspension, and 1 μL Phusion
enzyme (2,000 units/mL). The reactions were placed into a Peltier Thermal Cycler
(PTC). An individual cycle included heating the samples to 98°C for 10 seconds to
denature the DNA, cooling to 57°C for 30 seconds for annealing, and raising to 72°C for
two minutes to allow the DNA polymerase (Phusion enzyme) to add the appropriate
nucleotides. After 34 cycles, the temperature was maintained at 72°C for ten minutes to
allow for full extension of the products. PCR products were then held at 4°C until further
processing.

Agarose Gel Electrophoreses:
To ensure success, PCR products were visualized using gel electrophoresis. This
was performed using the Fisher brand electrophoresis units (Fisher Cat. No. FB-SB-710
or FB-SB R-1316). Electrophoresis was completed using 1.25% agarose gels consisting
of 1.25 g of agarose dissolved in 100 mL of 10X TAE buffer (per liter: 942 g Trizma
base, 150 mL 500mM EDTA, 67.1 mL Glacial Acetic Acid). The DNA size standards
used were a 𝜆 DNA/Hind III ladder (Fisher Cat. No. PR- G1711) and a 100 bp ladder
(Axygen Cat.No. M-DNA-100BP). The ladder sizes are labeled in the figures in the
results. Samples were prepared for electrophoresis by mixing 2 μL of Sambrook’s
loading dye (Sambrook & Russell, 2001) with 5 μL of PCR reaction. The expected
lengths of the PCR products were predicted using Table 2 and the Geneious Prime
software package (Biomatters, Inc., San Diego, CA). If the band sizes matched the
predicted size of the amplified fragment, the products were purified and prepared for
electroporation.
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Purification of PCR Products:
The Sigma-Aldrich GenElute PCR clean-up kit (Cat. No. NA1020) was used to
purify the PCR products. The directions from the kit were followed and the purified DNA
was recovered in elution buffer.

Buffer Exchange using a Centrifugal Filter Unit:
An additional round of purification was performed on the DNA substrate used for
recombineering to ensure the removal of salts. The DNA sample was mixed with water
(600 μL total volume) in an AmiconUltra 0.5 mL centrifugal filter unit (Fisher Cat. No.
UFC510096). The device was centrifuged for 10 minutes at 4,000 X g. The filtration
device was then flipped upside down, placed in a fresh 1.5 mL microcentrifuge tube, and
centrifuged for two minutes at 4,000 X g. The retentate contained approximately 20 μL of
the purified DNA in water. Purity and concentration were determined by
spectrophotometry.

Preparation of Electrocompetent Cells:
Host cells containing the HK639 prophage were prepared for electroporation for
each recombineering experiment. First, 5 mL of Luria Bertani (LB) broth (per liter: 10 g
Tryptone, 5 g yeast extract, and 5 g NaCl) was placed in a 15 mL conical tube and
inoculated with a loop full of RK1145 culture (Table 1). This culture was grown
overnight at 30°C with shaking at 250 rpm. The next day, 200 μL of the overnight culture
was transferred into a flask containing 30 mL of LB media. This subculture was grown at
30°C while shaking at 250 rpm until the optical density at wavelength 650 nm (OD650)
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reached 0.4-0.5. At this point, the culture was shifted to a 42°C water bath while shaking
at 250 rpm for 20 minutes to activate the expression of the recombination proteins. Strain
RK1145 contains plasmid pRK1006, from phage 𝛾, that possesses a temperaturesensitive repressor. Heating the culture to 42°C causes the repressor to denature and
allows for the promoter to transcribe the recombination function proteins which are then
released into the cell.
After the induction period, the culture was quickly cooled in an ice water bath to
allow for the repression of the recombination functions in the plasmid. It is important to
place the cells in an ice water bath to stop the transcription of the recombination
functions. The cooled culture was divided evenly into two 15 mL tubes and centrifuged at
1,000 X g at 4°C for 10 minutes. The pelleted cells were re-suspended in ice cold 10%
glycerol to remove any excess salts. The centrifugation and washing with ice cold 10%
glycerol were repeated twice. After the final centrifugation, the supernatant was poured
off and the cells were re-suspended in 40 μL of ice cold 10% glycerol. The
electrocompetent cells were always used immediately after preparation.
All electrocompetent cells and DNA were kept on ice during this part of the
experiment. One sample of cell suspension was used as a control (no substrate DNA
added). The other cell sample was combined with 200 ng of recombineering DNA
substrate. The cells were transferred by pipette to 2 mm electroporation cuvettes (Fisher
Cat. No. FB102) and subjected to a 2.5 kV electric shock. The Bio-Rad Gene Pulser
xCell was used to perform the electroporation.
After the electroporation event, 1 mL of Super Optimal broth with Catabolite
repression (SOC) broth (per liter: 20 g Tryptone, 5 g yeast extract, 0.5 g NaCl, 1.25 mL
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of 2M KCl, 5 mL 1M MgCl2, 1 mL 1M MgSO4, and 2 mL 1M glucose) was then added
to the cuvettes to provide the cells with a nutrient-rich medium. This mixture was
transferred into a 15 mL tube and was incubated at 30°C with shaking at 250 rpm for 1
hour to allow the cells to recover from the electroporation. The cells were then
transferred to 1.5 mL microcentrifuge tubes and spun at 1,000 X g until cells were
pelleted. The cells were re-suspended in 200 μL of LB media.
Using the spread plating technique, the cells were evenly distributed onto two LB
plates containing kanamycin (20 μg/mL) and incubated for 24 hours at 30°C. The
recovery of kanamycin-resistant colonies suggested that the recombination was
successful since the original strain is unable to grow in the presence of kanamycin.
Individual colonies were picked and streaked onto kanamycin plates (20 μg/mL) and
incubated at 30°C for 24 hours to purify the recombinants. Independent colonies were
then inoculated into 5 mL of LB media supplemented with kanamycin (20 μg/mL) and
grown overnight at 30°C with shaking at 250 rpm. The overnight cultures were
centrifuged at 1,000 X g for 10 minutes at 4°C. The supernatant was discarded, and the
cell pellet was re-suspended in 2.5 mL of 10mM MgSO4 and stored at 4°C.

Confirmation of Recombination Junctions:
To ensure that the kanamycin gene was inserted into the correct location in the
HK639 genome, the recombination junctions were amplified using PCR.
Oligonucleotides were designed to prime at each recombination junction (Table 2). Taq
polymerase was used to amplify the recombination functions (Fisher Cat. No. FB-600015). A typical 100 μL PCR reaction consisted of the following: 2 μL of the recombinant
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cell suspension (from an overnight culture), 30 μL 1.8 mM PCR mix, 1 μL Taq enzyme
(5,000 Units/μL), 64 μL water, and 100 pmole of each oligonucleotide. The amplification
products were run on a 1.25% agarose gel, as described above. A correctly sized product
(estimated using Geneious software and Table 2) indicated that the kanamycin gene
recombined in the appropriate location in the HK639 genome. The same analysis was
performed on purified phage stocks to confirm the released phage were indeed
recombinant.

Testing Recombinant Cells for Phage Release:
Lysogenic cells often spontaneously release phage as the release has an on and off
rate. Occasionally, the repressor falls off long enough for the genes to be transcribed and
expressed. This was verified to occur with the starting strain RK1145 (Table 1). To
determine if specific gene replacements affect phage production, supernatants from
overnight cultures were assayed for lytic activity. In addition, many prophages can be
induced to enter the lytic cycle by treating the cells with mitomycin-C, a DNA damaging
agent. Mitomycin-C has an indirect effect on the prophage. Once mitomycin-C has been
introduced, the bacterial cell releases a protein, rec-A, which stimulates the repressor of
the prophage to cleave itself and fall off. This allows for the expression of genes that
could cause the phage to grow lytically.
The recombinant cells were tested for both spontaneous phage release and
induced phage release by mitomycin-C. To perform these tests, two 5 mL stocks of
recombinant cells were grown in LB, supplemented with kanamycin (20 μg/ml), at 30° C
until the OD650 reached 0.3-0.4. At this point, 20 μL of a 50 mg/mL stock solution of
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mitomycin-C were added to one of the two cultures to induce phage release. Both
cultures were incubated at 30° C with shaking at 250 rpm overnight.
After overnight incubation, 50 μL of chloroform were added to each culture to kill
the cells and promote lysis. The cultures were thoroughly mixed and then centrifuged
for10 minutes at 12,000 X g. One mL of the supernatant was collected from each tube;
the lysed bacterial cells in the pellet and the chloroform were carefully avoided. An
indicator plate was prepared by mixing 4 mL of molten LB top agar with 80 μL of
overnight RK898 culture (Table 1). This mixture was poured onto an LB plate and evenly
distributed by gently swirling the plate. After solidifying, 10 μL of each purified
supernatant was spotted onto the plate. After the spots soaked in, the plate was incubated
at 37° C for 24 hours and then examined for plaque formation. If plaques appeared, they
were picked and suspended in 100 μL of 1X Phage Buffer (PB) (per liter: 10 mM Tris
Stock, 10mM MgSO4, 0.4% NaCl, and 1 mM CaCl2 stock).
The phage samples were diluted from concentrations of 100 to 10-5 and each
dilution was plated onto a lawn of indicator cells (as mentioned above). The plate was
incubated at 37°C for 24 hours. A plate containing confluent plaques (displaying a
“webby” pattern of plaques) was then flooded with 5 mL of 1X PB. The phage were
allowed to diffuse into the PB for 24 hours. The phage-rich stock was collected using a
10 mL syringe and was filtered through a Fisherbrand 25 mm syringe filter with 0.2 μm
pores. The titer of the phage lysate was determined by making serial dilutions (10-5 to 109

), using the methods described above. After incubation, the plates were examined, and

plates with 20-200 isolated plaques were counted. The titer was then determined using
the formula:
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phage forming units (pfu)
number of plaques
=
mL
dilution × volume plated

DNA Sequencing:
The recombination junctions were confirmed by DNA sequencing using the
BigDye Terminator v3.1 Cycle Sequencing Kit (ABI, Catalog No. 4337457). A typical
10 μL reaction contained 3 μL of the whole cell PCR reactions (see Confirmation of
Recombination Junctions), 2 μL of BigDye Terminator sequencing juice, 2 μL of 5X
BigDye Terminator sequencing buffer, and 100 pmol of a sequencing primer (Table 2).
The thermocycler settings were as follows: 25 cycles of 96°C for 30 seconds, 50°C for 15
seconds, 60°C for 4 minutes followed by a 10°C hold.
Upon completion, the sequencing reactions were purified using a SigmaSpin
Sequencing Reaction Clean-Up kit (Sigma Catalog No. S5059) following the
manufacturer’s instructions. The purified DNA was dried in a centrivap concentrator. The
sequencing products were then suspended in 20 μL of formamide and loaded into a 3130
ABI sequencer. The resultant sequences were then compared to the published HK639
genome in GenBank (Accession NC_016158) (King et al., 2011).
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RESULTS

Summary:
To identify essential genes in the left operon of HK639, five genes (ORF 39, ORF
40, ORF 41, ORF 42, and ORF 43) and a pair of transcription terminators were
systematically replaced. In each case, recombineering, a powerful chromosome
engineering technique, was used to replace the targeted sequences with a kanamycin
resistance gene.

Phage Recombineering:
Recombineering is a technique that allows for the precise replacement of genes
inside of cells. For this study, it was used to replace five genes and a regulatory sequence
in the left operon of HK639 with the kanamycin resistance gene. After the amplified
DNA substrate was electroporated into the cells and recombination occurred, the
recombineering substrate was verified. All recombineering experiments generated
recombinants as evidenced by the growth of kanamycin-resistant colonies (Figure 5).
Selecting for recombinants on a kanamycin plate is effective because cells that did not
successfully recombine are unable to grow in the presence of kanamycin.
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Figure 5: The plate on the right is the control kanamycin plate (20
μg/ml) and shows no colony formation. The plate on the left
depicts an example of recombinant colonies growing in the
presence of kanamycin (20 μg/ml). The ORF 43 recombinant is
shown here.

The recombination junctions were verified by amplifying the regions of interest
using PCR, and if the kanamycin gene was in the correct location, phage release was
observed. To test for the viability of the recombinant phages, the culture containing the
recombinants were place on a lawn of indicator cells. Clear plaques indicate lytic activity
as the bacteriophage has successfully lysed the bacterial cell. Most of the recombinants
released phage, and the morphology of the plaques stayed consistent throughout the
replacements. A typical plate exhibiting HK639 phage release on the indicator strain
RK898 (Table 1) can be seen in Figure 6. Details of each replacement are given below.
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Figure 6: Example of HK639 phage release on
an indicator strain RK898 (Table 1). Clear areas
(plaques) indicate lytic activity. Plaque
morphology remained consistent throughout this
study.

Terminator Sequence Replacement:
Two terminators in the left operon of HK639 were replaced with the kanamycin
resistance gene (Figure 4). The recombineering substrate was successfully generated on a
1.25% agarose gel (Figure 7) and kanamycin resistant recombinants were recovered. The
size band of 1,300 bp corresponds to the size of the kanamycin gene. The recombination
junctions were amplified by PCR and visualized using a 1.25% agarose gel (Figure 8). In
this replacement, the predicted sizes of the junctions (using Geneious and Table 2) were
540 bp and 586 bp.
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Lane
A-C
D-F

Figure 7:
Recombineering
substrate for the
terminator
replacement. The
1,300 bp band shown
in Lane 2 is the
expected size product.
The product was run
on a 1.25% agarose
gel. This figure has
been cropped to only
show the lanes in
question.

Oligos
758 x 291
570 x 290

Size
540 bp
586 bp

Figure 8: Verification of terminator replacement
recombination junctions. Lanes A-C are
amplification products from the upstream (Kan gene
N-terminus) recombination junction. All three
candidates generated a band of the expected size
(540 bp). Lanes D-F represent amplification products
from the downstream (Kan gene C-terminus)
recombination junction. All three candidates
generated a band of the expected size (586 bp).

Sequencing also verified the recombination junctions and that no unwanted
mutations were introduced through the amplification steps. Spontaneous release of phage
was not observed. However, when this recombinant was induced with mitomycin-C, a
single plaque was recovered. The single plaque was picked and subjected to several
rounds of purification. A high titer lysate (1.84 x 1010 pfu/mL) of the phage was
generated and tested by PCR to confirm that the phage contained the kanamycin gene in
the correct location.
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ORF 43 Replacement:
ORF 43 was replaced with the kanamycin resistance gene (Figure 4) as outlined
above. The recombineering substrate was successfully generated on a 1.25% agarose gel
(Figure 9) and kanamycin resistant recombinants were recovered. The size band of 1,300
bp corresponds to the size of the kanamycin gene. The recombination junctions were
amplified by PCR and visualized using a 1.25% agarose gel (Figure 10). In this
replacement, the predicted sizes of the junctions (using Geneious and Table 2) were 600
bp and 540 bp. Sequencing also verified the recombination junctions.

Lane
A-D
E-H

Figure 10:
Recombineering
substrate for the ORF
43 replacement. The
1,300 bp band shown in
Lane 2 is the expected
size product. The
product was run on a
1.25% agarose gel. This
figure has been cropped
to only show the lanes
in question.

Oligos
759 x 291
760 x 290

Size
600 bp
540 bp

Figure 9: Verification of ORF 43 replacement
recombination junctions. Lanes A-D are amplification
products from the upstream (Kan gene N-terminus)
recombination junction. All four candidates generated a
band of the expected size (600 bp). Lanes E-H
represent amplification products from the downstream
(Kan gene C-terminus) recombination junction. All four
candidates generated a band of the expected size (540
bp).
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The ORF 43 recombinant cells did not release phage spontaneously but did
release phage when induced with mitomycin-C. A single plaque was picked and
subjected to several rounds of purification. A high titer lysate (1.94 x 1011 pfu/mL) of the
phage was generated and tested by PCR to confirm that the phage contained the
kanamycin gene in the correct location.

ORF 42 Replacement:
ORF 42 was replaced with the kanamycin resistance gene (Figure 4). The recombineering
substrate was successfully generated on a 1.25% agarose gel (Figure 11) and kanamycin
resistant recombinants were recovered. The size band of 1,300 bp corresponds to the size
of the kanamycin gene. The recombination junctions were amplified by PCR and
visualized using a 1.25% agarose gel (Figure 11). In this replacement, the predicted sizes
of the junctions (using Geneious and Table 2) were 521 bp and 384 bp. Sequencing also

1.25% agarose gel

verified the recombi nation junctions.
Figure 11: Recombineering substrate for the
ORF 42 replacement. The 1,300 bp band
shown in Lane 2 is the expected size product.
The product was run on a 1.25% agarose gel.
This figure has been cropped to only show the
lanes in question.
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Lane
A, C, E, G
B, D, F, H

Oligos
760 x 291
761 x 290

Size
521 bp
384 bp

Figure 12: Verification of ORF 42
replacement recombination junctions.
Lanes A, C, E, and G are amplification
products from the upstream (Kan gene
N-terminus) recombination junction.
All four candidates generated a band
of the expected size (521 bp). Lanes B,
D, F, and H represent amplification
products from the downstream (Kan
gene C-terminus) recombination
junction. All four candidates generated
a band of the expected size (384 bp).

The ORF 42 recombinant cells released phage spontaneously and release was
stimulated by mitomycin-C treatment. A single plaque was picked and subjected to
several rounds of purification. A high titer lysate (1.44 x 109 pfu/mL) of the phage was
generated and tested by PCR to confirm that the phage contained the kanamycin gene in
the correct location.

ORF 41 Replacement:
ORF 41 was replaced with the kanamycin resistance gene (Figure 4). The
recombineering substrate was successfully generated on a 1.25% agarose gel (Figure 13)
and kanamycin resistant recombinants were recovered. The size band of 1,300 bp
corresponds to the size of the kanamycin gene. The recombination junctions were
amplified by PCR and visualized using a 1.25% agarose gel (Figure 14). In this
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replacement, the predicted sizes of the junctions (using Geneious and Table 2) were 577
bp and 462 bp. Sequencing also verified the recombination junctions.

Lane
A, C, E
B, D, F

Figure 14:
Recombineering
substrate for the ORF
41 replacement. The
1,300 bp band shown in
Lane 2 is the expected
size product. The
product was run on a
1.25% agarose gel. This
figure has been cropped
to only show the lanes
in question.

Oligos
761 x 291
762 x 290

Size
577 bp
462 bp

Figure 13: Verification of ORF 41 replacement
recombination junctions. Lanes A, C, and E are
amplification products from the upstream (Kan gene Nterminus) recombination junction. All three candidates
generated a band of the expected size (577 bp). Lanes B,
D, and F represent amplification products from the
downstream (Kan gene C-terminus) recombination
junction. All three candidates generated a band of the
expected size (462 bp).

The ORF 41 recombinant cells released phage spontaneously and release was
stimulated by mitomycin-C treatment. A single plaque was picked and subjected to
several rounds of purification. A high titer lysate (1.44 x 108 pfu/mL) of the phage was
generated and tested by PCR to confirm that the phage contained the kanamycin gene in
the correct location.
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ORF 40 Replacement:
ORF 40 was replaced with the kanamycin resistance gene (Figure 4). The
recombineering substrate was successfully generated on a 1.25% agarose gel (Figure 15)
and kanamycin resistant recombinants were recovered. The size band of 1,300 bp
corresponds to the size of the kanamycin gene. The recombination junctions were
amplified by PCR and visualized using a 1.25% agarose gel (Figure 16). In this
replacement, the predicted sizes of the junctions (using Geneious and Table 2) were 492
bp and 504 bp. Sequencing also verified the recombination junctions.

Lane
A-D
E-H

Figure 15:
Recombineering
substrate for the ORF 40
replacement. The 1,300
bp band shown in lane 2
is the expected size
product. The product was
run on a 1.25% agarose
gel. This figure has been
cropped to only show the
lanes in question.

Oligos
763 x 291
764 x 290

Size
492 bp
504 bp

Figure 16: Verification of ORF 40 replacement
recombination junctions. Lanes A-C are
amplification products from the upstream (Kan
gene N-terminus) recombination junction. All
three candidates generated a band of the expected
size (492 bp). Lanes D-F represent amplification
products from the downstream (Kan gene Cterminus) recombination junction. All three
candidates generated a band of the expected size
(504 bp).
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ORF 40 recombinants did not release phage under any condition. This test
indicated that ORF 40 was essential for either lytic phage release or phage replication.
We also cannot rule out the possibility that the ORF 40 knockout affected the expression
of a potentially critical downstream gene. To determine if ORF 40 itself was necessary,
two additional recombineering experiments were performed: one removing the adjacent
downstream gene (ORF 39) and one removing ORF 39 and ORF 40 together. The ORF
39 and ORF 40 replacement did not release phage. However, the ORF 39 replacement
released phage. In addition, the ORF 40 recombination junctions were amplified and
confirmed through sequencing. The results of sequencing indicated that the sequence of
the downstream gene was not affected by the knockout/insertion.
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DISCUSSION

The rise of antibiotic resistant bacteria has created a medical crisis.
Bacteriophages are a potential solution to this problem; however, very little is known
about bacteriophage gene function and biology. By identifying essential genes for lytic
growth in the left operon of HK639, this study adds to the knowledge of bacteriophage
gene expression and phage biology.
Bacteriophages HK022 and HK639 are similar in that they both use RNAmediated antitermination, a unique and poorly understood mechanism to control the
expression of their early genes. Surprisingly, HK022 can grow lytically even in the
absence of gene expression from its left operon. A similar result was expected with
HK639, but a previous study showed that the replacement of the HK639 left operon
genes prevented phage release from an HK639 lysogen (Seaton, 2013).
It was assumed that the phage integrase gene, which plays a role in phage
excision from the host genome, was the only gene in the left operon essential for lytic
growth, therefore preventing phage release when the left operon expression was blocked.
However, the results of this study demonstrate that a(n) additional left operon gene(s) is
also crucial for phage release. The necessity of this gene was initially shown by the lack
of plaque formation when ORF 40 was replaced with the kanamycin resistance gene.
The lack of phage release indicates that either the expression of this gene is
essential for lytic growth and release, or the replacement of this gene interfered with the
expression of essential downstream genes. It was possible that the ORF 40 knockout
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interfered with the expression of the adjacent downstream gene, ORF 39 (phage-related
recombinant protein) (Accession NC_016158) (NCBI, 2020). Additional knockouts,
however, showed that when ORF 39 and ORF 40 were replaced together, phage release
was blocked, but a replacement of ORF 39 alone allowed for the release of phage. These
results suggest that the replacement of ORF 40 did not interfere with ORF 39, and that
ORF 40 may perform an essential function for phage release.
In addition, the kanamycin promoter is not identical to the promoter of the gene it
replaced, which may have altered the expression of downstream genes critical to phage
release. If ORF 40 contains a promoter for a downstream essential gene, and the
kanamycin promoter does not promote for the expression of this same gene, this could
prevent phage release. This may mean these genes (and possibly additional downstream
genes) work together to promote phage growth and release, and that interference with any
single component prevents phage release.
When ORF 40 was “BLAST-ed” (searched against all documented phage genes in
the national DNA sequence database), there was no significant matches. The lack of
known function further illustrates that that little is known about bacteriophage genetics,
even genes that may be crucial for phage release.
Whether ORF 40 is essential for phage release or the knockout interfered with the
expression of crucial downstream genes, our results demonstrate that the alteration of
specific genes of the left operon has detrimental effects on HK639 lytic growth. Based on
studies of other phages, the replacements may have interfered with the excision of the
phage from the host’s genome or the replication of the phage. This study has identified
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the players, but further work is now needed to identify the way in which phage excise and
replicate. Additional studies are needed to distinguish between these possibilities.
Lytic phage do not need to express genes used for excision from the host cell’s
genome. Lytic phage can simply infect the bacterium, replicate and assemble the viral
parts, and lyse the cell. This process does not involve the phage integrating its DNA into
the host’s genome. However, with current technology and recombineering, bacteriophage
genes are nearly impossible to alter unless they are in the lysogenic state inside the host’s
genome. If the replication of the phage is inhibited, then lytic phage truly cannot grow
without the expression of that gene because it cannot synthesize more viral parts. If the
gene replacement affects excision from the host genome, however, then a crucial step of
the lysogenic life cycle is inhibited, not necessarily lytic growth.
The HK639 left operon contains two adjacent transcription terminators located
downstream of the antiterminator RNA element (putL). It was expected that the removal
of these terminators would result in increased phage release since it would no longer be
necessary to promote the readthrough of the terminator pair. Surprisingly, phage release
was significantly reduced compared to the other recombinants generated in this study;
only 1-3 plaques recovered per phage release experiment. Interestingly, the recombinant
phage was perfectly capable of growing to high titers. This suggests that antitermination
is important for phage excision and that the recombinant is deficient in this step of the life
cycle. After excision, the recombinant phage appeared to grow normally.
The replacement of ORF 39, ORF 41, ORF 42, and ORF 43 did not prevent phage
release. These results clearly demonstrate that these genes are not essential for lytic
growth in a lab environment. However, organisms tend not to maintain useless functions.
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Perhaps these genes are necessary for a different step in the phage life cycle (e.g.
lysogeny), or perhaps they are critical under conditions that are different from a lab.
Historically, understanding basic phage biology has led to the discovery of novel
regulatory mechanisms (e.g. lysis-lysogeny decisions, RNA-mediated antitermination,
etc.) and it has provided revealing insights into virus-host interactions. Expanding our
understanding of these simple viruses will provide the insight needed to exploit these
natural parasites to benefit human health and help us deal with the menace of antibiotic
resistant microbes.
In this study, modifications in the DNA sequence were achieved using phage
mediated recombineering. A cloned plasmid, from bacteriophage 𝜆, catalyzed the
reaction and allowed for recombination functions to be expressed. However, there is a
new mechanism of chromosome engineering that is on the frontier of microbiology and
has been used to manipulate the genomes of plants and animals. The CRISPR-Cas 9
system is not only easy to use but is also cost effective (Doudna & Charpentier, 2014).
CRISPR is short for “Clustered regularly interspaced short palindromic repeats”,
and Cas 9 is an associated protein to CRISPR that acts as an endonuclease. CRISPR-Cas
9 takes advantage of a naturally occurring mechanism. Originally, CRISPR was
identified in bacteria as an immune system, but this newly discovered mechanism has
since been modified and exploited to perform controlled, site-specific modifications in
DNA. It functions by forming base pairs with targeted DNA sequences which then allows
the endonuclease to perform two site-specific breaks in the DNA (Doudna & Charpentier,
2014).
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To do this, CRISPR-Cas 9 works in two parts: the chimera (guide) RNA and the
Cas 9 protein. To cut a specific sequence of DNA, the target sequence is identified. The
guide RNA is then manipulated to contain homologous pairs that will bind to the target
sequence. The DNA is then fed through the complex, and CRISPR contains helicases that
unwind the DNA. When the guide RNA aligns with the target sequence, it holds it there
while Cas 9 cleaves the DNA at two site-specific locations. This is shown in Figure 17.

Figure 17: Displays how
CRISPR-Cas 9 functions
(Redman et al., 2016). The
guide RNA (yellow) is
specifically designed to be
homologous to a certain
sequence of the target DNA
(blue). Once these sequences
align, the Cas 9 protein then
cleaves the target DNA in two
site-specific locations (indicated
by the scissors).

In other words, at the 5’ side, there is a DNA target site, and at the 3’ side, there is
a structure that binds to Cas 9 (Ran et al., 2014). The associated proteins to CRISPR can
ultimately be modified to contain different functions. For example, instead of just simply
cutting the DNA, a gene can be removed and replaced with a new gene, or, a site-specific
base pair change can be generated. This genomic engineering technique is more specific,
extremely versatile, easier to construct, and is very efficient. The use of this genomic
engineering technique is also much quicker than the recombineering used in this lab.
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CONCLUSION AND FUTURE WORK

During this experiment, recombineering was used to replace six genetic sequences
in the left operon of lysogenic E. coli bacteriophage HK639. After replacing the six
genetic sequences, phage release tests were conducted to determine the importance of
each genetic sequence. Out of the six different replaced genetic sequences, five of the
sequences released phage: the terminator replacement, ORF 39, ORF 41, ORF 42, and
ORF 43. The plaques formed by the released phage were characterized and compared.
Our results show that these genes and regulatory sequence are thus non-essential for the
lytic growth of bacteriophage HK639.
No phage were released from the ORF 40 knockout. Gene replacements were
performed to determine whether ORF 39 or ORF 40 was important or if the knockouts
were affecting downstream genes. Because ORF 39 and ORF 40 replacements did not
release phage, but ORF 39 did, it can be determined that ORF 39 is not essential for lytic
release but ORF 40 is. Whether this gene itself is crucial for lytic release or if this
replacement affects the expression of crucial downstream genes is inconclusive, however.
Further research is necessary to identify additional essential genes that are
necessary for supporting phage growth in bacteriophage HK639. There may be additional
genes in the left operon that are essential for lytic growth. The remaining genes in the left
operon should be knocked out and tested for phage release as was done in this study.
Additionally, further biochemical analysis of ORF 40 needs to be conducted. This may
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reveal its function and determine why it is essential and if it affects the replication or
excision of the phage.
In the future, there are two particular experiments that can be performed to
determine if ORF 40 affects excision or replication, and if it does, which one. A real time
PCR could be used to determine if the bacteriophage replicates in the absence of ORF 40.
If the number of copies of the phase increases, this would suggest that the phage is in fact
replicating. A complementation assay could be generated to determine if excision is
affected by the removal of ORF 40. An excision gene can be cloned and placed into the
cell. If this replacement of the excision gene ultimately allows for phage release, then it
can be concluded that ORF 40’s function is related to excision.
Ultimately, this information provides the groundwork for viral genetics. In order
to combat anti-biotic resistant bacteria, bacteriophage and their gene functions must first
be understood. For example, a cytotoxicity assay could be completed for each of the
genes to determine if they have an impact on cell growth. Knowing which genes code for
certain functions under certain conditions can eventually allow for them to be
manipulated so that bacteriophages can act as therapeutic agents.
It is also worth noting that in future experiments, a new genomic engineering
technique, CRISPR-Cas 9, could be used. The technique used in this lab is somewhat
limited. For recombineering, a strain with a plasmid with recombination functions had to
be used. Many overnight cultures had to be obtained and there were several hours of
preparation work. However, with CRISPR-Cas 9, the opportunities are endless. If
CRISPR-Cas 9 was used for this experiment, it would be a lot quicker and require less
downtime, would require less resources, and would be more efficient.
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Without a solution, antibiotic-resistant bacteria will have detrimental effects on
humanity. However, bacteriophages may be a useful weapon to control the threat. Further
investigation of bacteriophage gene function brings us one step closer to exploiting their
use as bactericidal agents to control human infections. In addition, analyses such as this
deepen our understanding of viruses in general, and this could help us control global
pandemics like COVID-19.
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